Opinion|Videos|October 31, 2023
Current Therapies and Treatment Approaches for ABSSSI
Author(s)George Sakoulas, MD
An expert in infectious diseases reviews currently available therapeutic options for inpatient and outpatient treatment of ABSSSI and examines the advantages of using single-dose agents in patients.
Advertisement
Advertisement
Related to this article
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with Staphylococcus aureus Bacteremia (SAB). This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline.
Advertisement
Advertisement
Trending on Contagion Live
1
A Closer Look at IDSA/ESCMID 2026 Consensus Statements 6 and 7 on Staphylococcus aureus Bacteremia
2
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
3
Thinking Outside the IV: Implementation of a COpAT Program for Patients With Bone and Joint Infections
4
Early Dual Therapy Shortens Staphylococcus aureus Bacteremia in SABEDTIO Trial
5